Literature DB >> 20369354

Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats.

Gregory V Carr1, Irwin Lucki.   

Abstract

RATIONALE: Recent evidence suggests a role for the dynorphin/kappa-opioid receptor (KOR) system in the expression of stress-induced behaviors. Wistar Kyoto (WKY) rats exhibit increased depression-like and anxiety-like responses in behavioral tests compared to other strains and may be a model of comorbid depression and anxiety characterized by increased activity within the dynorphin/KOR system. Though KOR antagonists produce antidepressant-like effects in WKY rats, their effects in tests of anxiety-like behavior have not been examined in the WKY strain.
OBJECTIVE: The aim of the current study was to investigate the effects of the KOR antagonist 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl]acetamide hydrochloride (DIPPA) on the behavior of WKY rats and Sprague Dawley (SD) rats in tests of anxiety-like behavior.
METHODS: The novelty-induced hypophagia and defensive burying tests were used to measure anxiety-like behavior in WKY and SD rats and determine the effects of DIPPA on anxiety-like behavior in both strains.
RESULTS: WKY rats displayed greater amounts of anxiety-like behavior compared to SD rats. DIPPA produced anxiolytic-like effects in both tests in both strains.
CONCLUSIONS: WKY rats display more anxiety-like behavior at baseline compared to SD rats, and DIPPA produced anxiolytic-like effects in both WKY and SD rats. These findings support previous research suggesting that KOR antagonists possess anxiolytic-like properties and may potentially represent a novel class of treatments for mood disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20369354      PMCID: PMC3370387          DOI: 10.1007/s00213-010-1832-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

1.  X-linked and lineage-dependent inheritance of coping responses to stress.

Authors:  Nasim Ahmadiyeh; Gary A Churchill; Kazuhiro Shimomura; Leah C Solberg; Joseph S Takahashi; Eva E Redei
Journal:  Mamm Genome       Date:  2003-11       Impact factor: 2.957

2.  Intraventricular insulin decreases kappa opioid-mediated sucrose intake in rats.

Authors:  A J Sipols; J Bayer; R Bennett; D P Figlewicz
Journal:  Peptides       Date:  2002-12       Impact factor: 3.750

3.  Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice.

Authors:  Zul Merali; Carla Levac; Hymie Anisman
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

4.  Strain differences in the distribution of dopamine transporter sites in rat brain.

Authors:  Xilu Jiao; William P Paré; Shanaz Tejani-Butt
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-09       Impact factor: 5.067

5.  Effects of chronic fluoxetine in animal models of anxiety and depression.

Authors:  Stephanie C Dulawa; Kerri A Holick; Brigitta Gundersen; Rene Hen
Journal:  Neuropsychopharmacology       Date:  2004-07       Impact factor: 7.853

6.  A sensitive open field measure of anxiolytic drug activity.

Authors:  D R Britton; K T Britton
Journal:  Pharmacol Biochem Behav       Date:  1981-10       Impact factor: 3.533

7.  Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses.

Authors:  Jay P McLaughlin; Monica Marton-Popovici; Charles Chavkin
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

8.  A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression.

Authors:  Richard De La Garza; James J Mahoney
Journal:  Brain Res       Date:  2004-09-24       Impact factor: 3.252

9.  Chronic cold stress sensitizes brain noradrenergic reactivity and noradrenergic facilitation of the HPA stress response in Wistar Kyoto rats.

Authors:  Marie-Christine Pardon; Shuaike Ma; David A Morilak
Journal:  Brain Res       Date:  2003-05-02       Impact factor: 3.252

10.  Sex- and lineage-specific inheritance of depression-like behavior in the rat.

Authors:  Leah C Solberg; Amber E Baum; Nasim Ahmadiyeh; Kazuhiro Shimomura; Renhua Li; Fred W Turek; Gary A Churchill; Joseph S Takahashi; Eva E Redei
Journal:  Mamm Genome       Date:  2004-08       Impact factor: 2.957

View more
  30 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.

Authors:  Caroline A Browne; Rebecca L Erickson; Julie A Blendy; Irwin Lucki
Journal:  Neuropharmacology       Date:  2017-02-07       Impact factor: 5.250

3.  Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.

Authors:  Rachel I Anderson; David E Moorman; Howard C Becker
Journal:  Handb Exp Pharmacol       Date:  2018

4.  Kappa opioid receptors in the bed nucleus of the stria terminalis regulate binge-like alcohol consumption in male and female mice.

Authors:  Harold L Haun; William C Griffin; Marcelo F Lopez; Howard C Becker
Journal:  Neuropharmacology       Date:  2020-02-02       Impact factor: 5.250

5.  Stress-induced epigenetic regulation of κ-opioid receptor gene involves transcription factor c-Myc.

Authors:  Shlomit Flaisher-Grinberg; Shawna D Persaud; Horace H Loh; Li-Na Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

6.  Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice.

Authors:  Kevin K Ogden; Alpa Khatri; Stephen F Traynelis; Scott A Heldt
Journal:  Neuropsychopharmacology       Date:  2013-09-06       Impact factor: 7.853

Review 7.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

Review 8.  Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.

Authors:  William A Carlezon; Andrew D Krystal
Journal:  Depress Anxiety       Date:  2016-10       Impact factor: 6.505

9.  Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity.

Authors:  Ashlee Van't Veer; Anita J Bechtholt; Sara Onvani; David Potter; Yujun Wang; Lee-Yuan Liu-Chen; Günther Schütz; Elena H Chartoff; Uwe Rudolph; Bruce M Cohen; William A Carlezon
Journal:  Neuropsychopharmacology       Date:  2013-02-27       Impact factor: 7.853

10.  Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice.

Authors:  Edgardo Falcon; Kaitlyn Maier; Shivon A Robinson; Tiffany E Hill-Smith; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2014-09-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.